Advanced HIV study in Zambia for those starting HIV treatment
Part of Infections clinical trials.
This study looks at people with advanced HIV disease during their first months on antiretroviral therapy (ART). It aims to understand and improve care for those who start treatment when their immune system is weak.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have HIV and are not yet on treatment, or have been on it for less than 6 months.
- You have been checked for advanced HIV disease (a weak immune system) at the clinic.
- You agree to join the study and sign a consent form.
- You are not pregnant or in antenatal care, and you are well enough to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people with advanced HIV stay in care after being hospitalized. If you have a very low CD4 count or a serious HIV-related illness, this study may offer extra support to keep you healthy.
This trial looks at whether staying in contact with patients after they leave the hospital helps them get better follow-up care. If you have advanced HIV and are in the hospital for a related illness, you may be able to join.
This trial uses health records to learn how people in Zambia access HIV care and treatments. It may help improve future HIV support and treatment planning.
This research study follows people with hepatitis B (a liver infection) in Zambia to understand how their bodies respond to treatment and what happens to the virus over time. It includes people with hepatitis B alone, those also living with HIV, and those whose hepatitis B has cleared.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
Hear when a new Advanced HIV Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.